Covenant Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $400K | Hold |
|
|||||
|
2021
Q1 | $333K | Sell |
|
|||||
|
2020
Q4 | $625K | Hold |
|
|||||
|
2020
Q3 | $457K | Hold |
|
|||||
|
2020
Q2 | $449K | Sell |
|
|||||
|
2020
Q1 | $368K | Sell |
|
|||||
|
2019
Q4 | $509K | Hold |
|
|||||
|
2019
Q3 | $461K | Sell |
|
|||||
|
2019
Q2 | $642K | Hold |
|
|||||
|
2019
Q1 | $662K | Sell |
|
|||||
|
2018
Q4 | $820K | Hold |
|
|||||
|
2018
Q3 | $820K | Hold |
|
|||||
|
2018
Q2 | $732K | Sell |
|
|||||
|
2018
Q1 | $2.32M | Buy |
|
|||||
|
2017
Q4 | $2.35M | Sell |
|
|||||
|
2017
Q3 | $2.85M | Sell |
|
|||||
|
2017
Q2 | $2.49M | Buy |
|
|||||
|
2017
Q1 | $2.16M | Buy |
|
|||||
|
2016
Q4 | $2.09M | Buy |
|